简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Mabwell
Mabwell(02493.HK): Injection 9MW5211 Approved by NMPA for Clinical Trials in Multiple Sclerosis
Tags：
Mabwell
02493.HK
2026-06-25
Mabwell(02493.HK) Elects Dr. Gui Xun as Employee Representative Director
Tags：
Mabwell
02493.HK
2026-06-18
Mabwell (02493.HK) Sets Offer Price at HK$27.64, Expected to List on April 28
Tags：
02493.HK
Mabwell
offer price
2026-04-24
Mabwell (02493.HK) Commences Hong Kong IPO, Secures US$53 Million from 6 Cornerstone Investors
Tags：
Mabwell
02493.HK
IPO
public offering
2026-04-20
Featured News
Finance
CICC (03908.HK): Coupon Rate of Corporate Bond "21 CICC G6" Cut to 1.30%
Research
Daily Report on Hong Kong-Listed LLM Concept Stocks (July 20, 2026)
Finance
FriendTimes (06820.HK): Positive Profit Forecast, Interim Profit Expected to Rise 67% to 82%
Finance
Lee & Man Paper (02314.HK): Positive Profit Warning, Interim Profit Expected to Surge 64%-71%
ETF
Hang Seng High Dividend 30 Index Etf(03466.HK) Rises 1.42% Intraday with AUM of HK$13.423 Billion
ETF
ChinaAMC HSI ESG ETF(03403.HK) Rises 1.61% Intraday, NAV Per Unit at HK$50.732
ETF
Ping An of China CSI HK Dividend ETF(03070.HK) Rises 2.53% Intraday at HK$40.48
ETF
Southern A50 ETF (02822.HK) Rises 1.78% Intraday with AUM of HK$6.963 Billion
ETF
Tracker Fund Of Hong Kong(02800.HK) Rises 1.84% Intraday with Turnover of HK$14.418 Billion
ETF
Samsung Bloomberg Global Semiconductor Etf(03132.HK) Rises 2.43% Intraday at HK$61.56
Scan QR Code
Download App
